ScholarWorks@Hanyang University: Jun, Jae Bum

Detailed Information

Jun, Jae Bum (전재범)

COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)

Research Area

Tel 02-2290-9244
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Rheumatoid arthritis:21||Gout:8||rheumatoid arthritis:6||Scleroderma:6||Hyperuricemia:6||Prevalence:6||Uric acid:6||Bleomycin:5||s disease:5||Korea:5||Arthritis:4||Systemic sclerosis:4||ankylosing spondylitis:4||TNF inhibitor:4||rheumatoid:4||Dermatomyositis:4||Rheumatoid:3||Methylcellulose gel:3||Safety:3||arthritis:3||Fracture:3||ossification of posterior longitudinal ligament:3||Ankylosing spondylitis:3||Osteoarthritis:3||polymorphism:3||Osteomalacia:2||Osteoporosis:2||Uveitis:2||Hypouricemia:2||Rectus sheath hematoma:2||Reflux esophagitis:2||Latent tuberculosis:2||sesamoid bone:2||Behcet&apos:2||systemic sclerosis:2||tomography:2||Leukopenia:2||Animal model:2||uric acid:2||Risk factors:2||Connective tissue diseases:2||Infliximab:2||clinical trial:2||Acute myocardial infarction:2||Cyclophosphamide:2||DAS28:2||Cytochrome P450:2||Interstitial lung disease:2||Atrial fibrillation:2||Irritable bowel syndrome:2||BuddChiari syndrome:2||Epidemiology:2||Systemic lupus erythematosus:2||Prognosis:2||genetic:2||hyperuricemia:2||Adefovir dipivoxil:2||Myonecrosis:2||Discordance:2||methotrexate:2||methylenetetrahydrofolate reductase:2||Quality of life:2||Nephrotoxicity:2||Apigenin:2||osteoarthritis:2||Flavonoid:2||prevalence:2||Tropheryma whippelii:2||Hypophosphatemia:2||Tumor necrosis factor inhibitor:2||Ulnar artery:2||HEPATITIS B VIRUS:1||HIRA:1||HLAB*58:01 allele:1||HOUSEHOLD:1||HOXD gene:1||HPRT:1||Hand:1||Hemorrhage:1||Hypertension:1||IL1 beta:1||IgA nephropathy:1||Immunoglobulin G4:1||Immunosuppressant:1||Incidence:1||Inflammation:1||Influencing factors:1||InterferonGamma Release Assay:1||Interleukin18:1||Interstitial:1||Interstitial lung diseases:1||Intestine:1||Isoniazid:1||Joint contracture:1||Joint involvement:1||Juvenile rheumatoid arthritis:1||Knee:1||Knuckle pads:1||Korean:1||Korean National Health Insurance reimbursement criteria:1||Korean Red Ginseng:1||Korean validation:1||Latent Tuberculosis Infection:1||Leflunomide:1||LeschNyhan:1||Lobular panniculitis:1||Lung:1||Lung diseas:1||Lupus erythematosus, Systemic:1||MEFV:1||MORTALITY:1||Macrophages:1||Malignancy:1||Mapping:1||Matrix metalloproteinase:1||Metaanalysis:1||Meteorology:1||Microscopic polyangiitis:1||Mitochondria:1||Mitochondrial DNA:1||Monckeberg&apos:1||Motor neuron disease:1||NEOPLASMS:1||NSAID:1||NSAIDs:1||Nontuberculous mycobacterium:1||OCCULT INFECTION:1||Ossification of posterior longitudinal ligament:1||Osteoarthritis of the knee:1||Outcome measures:1||Overlap syndrome:1||Pachydermodactyly:1||Pachydermoperiostosis:1||Pain:1||Pain control:1||Patient global assessment:1||Patients:1||Peripheral arterial disease:1||Peripheral blood stem cell transplantation:1||Physician global assessment:1||Pneumatosis cystoides intestinalis:1||Pneumocystis jirovecii:1||Pneumomediastinum:1||Polymorphism:1||Polymyalgia Rheumatica:1||Polymyositis:1||Polyneuropathy:1||Population:1||Primary Sjogren&apos:1||Primary hyperparathyroidism:1||Publication:1||Pulmonary:1||Pulmonary fibrosis:1||Pulmonary hypertension:1||Pulse wave velocity:1||QuantiFERONTB gold in tube test:1||Quantitative sensory testing:1||REPUBLIC OF KOREA:1||RHEUMATIC DISEASES:1||RHEUMATOID ARTHRITIS:1||Radiography:1||Radiology:1||Ranawat value:1||Raynaud&apos:1||Reactive oxygen species:1||Registry:1||Remission:1||Renal insufficiency:1||Rheumatologists:1||Rheumatology:1||SEX:1||SKI306X:1||SYSTEMIC SCLEROSIS:1||Seasonality:1||Seasons:1||Secondary gout:1||Sesamoid bone:1||Sleep:1||Spondylitis, Ankylosing:1||Spondyloarthropathies:1||Still disease:1||Summer:1||Synovial Fluid:1||Synovitis:1||Systematic review:1||Systemic:1||Systemic onset:1||Systemic scleroderma:1||TFB2M:1||TNFalpha blockers:1||TNFblocker:1||TNFα:1||TNFRFc Fusion Protein:1||TUMOR NECROSIS FACTORalpha BLOCKER:1||Temperature:1||Tendon friction rub:1||Transcription factors:1||Treatment:1||Treatment guideline:1||Tuberculosis:1||Uric Acid:1||Utility:1||Vascular calcification:1||Vasculitis:1||Vasculopathy:1||adultonset Still&apos:1||antirheumatic agents:1||atlantoaxial subluxation:1||atlantodental interval:1||autoimmune diseases:1||autosomal dominant tubulointerstitial kidney disease:1||biological therapy:1||body mass index:1||bone density:1||cerebrovascular disorder:1||cervical spine:1||cervical spine instability:1||chondrocalcinosis:1||chronic kidney disease:1||cognitive impairment:1||cohort study:1||connective tissue disease:1||costeffectiveness analysis:1||cyclooxygenase2:1||digital ulcer:1||disease activity:1||disease activity score:1||education:1||effect:1||epidemiology:1||femur:1||foot joints:1||gastrointestinal tract:1||hand joints:1||homocysteine:1||hyponatremia:1||hypouricemia:1||incidence:1||knee:1||latent tuberculosis infection:1||misoprostol:1||mitochondrial DNA:1||noninferiority:1||observational cohort study:1||osteoarthritis of knee:1||osteoporosis:1||prognosis:1||prospective study:1||pulmonary arterial hypertension:1||rebamipide:1||registries:1||rheumatic disease:1||rheumatoid factor:1||s phenomenon:1||s sclerosis:1||s syndrome:1||safety:1||scleroderma:1||scoring methods:1||single nucleotide polymorphism:1||singlenucleotide polymorphism:1||subaxial subluxation:1||subaxial translation:1||tacrolimus:1||treatment:1||tuberculin skin test:1||tumor necrosis factor inhibitor:1||vertebral fracture:1||vertical subluxation:1||간질성 폐질환:1||강직척추염:1||골연화증:1||신독성:1||아데포비어:1||저인산염혈증:1||전신경화증:1||창자벽 공기 낭증:1||1,25Dihydroxyvitamin D3:1||피부근염:1||ABCG2:1||Abstract:1||Adalimumab:1||Adult onset Still&apos:1||Adverse effects:1||Aggrecanase:1||Allopurinol:1||Anklebrachial index:1||Ankylosing Spondylitis:1||AntiTNF drugs:1||AntiTumor Necrosis Factor:1||Antineutrophil cytoplasmic antibody:1||Aortic valve insufficiency:1||Arterial stiffness:1||Arteriography:1||Autism spectrum disorder:1||BASDAI:1||Behçet&apos:1||Beverages:1||Bone Mineral Density:1||Bosentan:1||Brachydactyly:1||COL6A1:1||COMPLEMENTARY AND ALTERNATIVE MEDICINE:1||COVID19:1||Caffeine:1||Calcium pyrophosphate dihydrate deposition disease:1||Cartilage:1||Caspase1:1||Cervical spine:1||Chronic:1||Chronic kidney diseases:1||Climate change:1||Clinical Effectiveness:1||Clinical characteristics:1||Coffee:1||Cohort:1||Cohort studies:1||Copy number variations:1||DEPRESSION:1||DMARDs:1||Death:1||Dermatomyositis/polymyositis:1||Digital tomosynthesis:1||Drug delivery system:1||Drug efficacy:1||Drug hypersensitivity:1||Drug persistency:1||Drug retention rate:1||E148Q:1||EPIDEMIOLOGY:1||EQ5D:1||Early diagnosis:1||Education:1||Elderly:1||Emphysema:1||Fabella:1||Fanconi syndrome:1||Fatigue:1||Five dimensions:1||Flares:1||Fractures:1||Frequency:1||GWAS:1||Gastrointestinal diseases:1||Gout Onset:1||Gout/Arthritis:1||Guidelines:1||HAQ:1||HAQDI:1||

STATISTICS: Total View :5,077,276; Today View :105

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE